Diaxonhit SA Share Price Euronext Paris
Equities
ALEHT
FR0013240934
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
08/05 | Eurobio Scientific: agreement with Myriad Genetics | CF |
08/05 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
Sales 2023 | 13Cr 14Cr 1.18TCr | Sales 2024 * | 14Cr 15Cr 1.25TCr | Capitalization | 15Cr 16Cr 1.35TCr |
---|---|---|---|---|---|
Net income 2023 | 40L 43.47L 36Cr | Net income 2024 * | 90L 97.81L 81Cr | EV / Sales 2023 | 1.29 x |
Net Debt 2023 * | 2.3Cr 2.5Cr 208.2Cr | Net cash position 2024 * | 99L 1.08Cr 90Cr | EV / Sales 2024 * | 1.01 x |
P/E ratio 2023 |
38.3
x | P/E ratio 2024 * |
15.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.3% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 19/17/19 |
Director of Finance/CFO | 43 | 01/22/01 | |
Cathie Marsais
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 19/17/19 |
Director/Board Member | 68 | 04/09/04 | |
Director/Board Member | 67 | 15/17/15 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr | |
-6.26% | 1.14TCr |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock